Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2011
06/15/2011EP2331581A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments
06/15/2011EP2331113A1 Complement inhibitors for treatment of injury form intracerebral hemorrhage
06/15/2011EP2330897A1 Ngal-binding siderophores and use thereof to treat iron deficiency and iron overload
06/15/2011EP2330895A1 Short acting benzothiazepine calcium channel blockers and uses thereof
06/15/2011CN201861992U Multiple coating mirco-capsulation lactic acid bacteria (MCM-LAB) structure
06/15/2011CN1832948B 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists
06/15/2011CN102099340A Heterocyclic compounds as factor IXA inhibitors
06/15/2011CN102099042A Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections
06/15/2011CN102093598A Composite edible fungi polysaccharides and preparation method thereof
06/15/2011CN102093285A Cyclic amide derivatives, and their production and use as antithrombotic agents
06/15/2011CN102093261A Salicylic acid metformin salt and preparation method and medical application thereof
06/15/2011CN102091345A Sodium alga acid composition and application thereof
06/15/2011CN102091292A Traditional Chinese medicine composition for treating hemophilia
06/15/2011CN102091242A Traditional Chinese herbal medicament for treating various fish diseases
06/15/2011CN102091237A Product for nano magnetic-anion far-infrared functional dress therapy
06/15/2011CN102091230A Process for extraction and preparation of composition of Chinese date and manyflower solomonseal rhizome
06/15/2011CN102091208A Nanometer selenium-germanium snake-bee element traditional Chinese medicinal far-infrared negative ion anti-electromagnetic wave body-strengthening dissolved medicine
06/15/2011CN102091173A Method for processing rehmannia root
06/15/2011CN102091132A Method for detecting esculin, aesculetin, fraxin and fraxetin in cortex fraxini or extract thereof
06/15/2011CN102091081A Composition for preventing or treating apoplexy and application thereof
06/15/2011CN102091049A Matrine dispersible tablet and preparation process thereof
06/15/2011CN102091046A Fludarabine phosphate freeze-dried powder injection and preparation method thereof
06/15/2011CN102091040A Preparation process of fine rutin particles
06/15/2011CN102091030A Vinpocetine injection and preparation method thereof
06/15/2011CN102090622A Sparassia crispa(Wulf.)Fr. solution preparation method
06/15/2011CN101797310B Fat reduction traditional Chinese medicine composite capable of removing dampness and absorbing clot as well as activating blood circulation and dissipating blood stasis
06/15/2011CN101766804B Chinese herbal composite for epistaxis treatment and preparation method thereof
06/15/2011CN101757541B Traditional Chinese medicine composition for treating liver ascites symptoms and preparation method thereof
06/15/2011CN101647945B Traditional Chinese medicine for treating cerebral thrombosis
06/15/2011CN101637558B Medicament for treating thrombocytolytic purpura
06/15/2011CN101623409B Traditional Chinese medicine preparation for treating apoplexy
06/15/2011CN101601815B Medicament for hemostasis
06/15/2011CN101434964B Cholera toxin B subunit and lumbrokinase fusion gene, as well as recombinant vector and host cell including the same
06/15/2011CN101322791B Chinese medicine for treating chronic anemia
06/15/2011CN101066125B Instant ass-hide gelatin powder and prepn and their prepn process
06/15/2011CN101044120B Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
06/15/2011CN101035759B Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
06/15/2011CN100998651B Medicine for treating thromboembolia type disease and its preparing method
06/14/2011USRE42461 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
06/14/2011US7960433 Treatment of chemokine mediated diseases
06/14/2011US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
06/14/2011US7960411 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
06/14/2011US7960369 Receptor function regulator
06/14/2011US7960340 Cystine knot molecules
06/14/2011CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/14/2011CA2495661C Inhibition of phosphoinositide 3-kinase beta
06/14/2011CA2492378C Modified amino acid for the inhibition of platelet aggregation
06/14/2011CA2476177C Purification of red blood cells by separation and diafiltration
06/14/2011CA2437966C 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
06/14/2011CA2433667C Prodrugs of excitatory amino acids
06/14/2011CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers
06/14/2011CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
06/14/2011CA2425311C Ketone compounds and compositions for cholesterol management and related uses
06/14/2011CA2416673C Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same
06/09/2011WO2011068211A1 2-pyridone compounds
06/09/2011WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives
06/09/2011WO2011067571A1 Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor
06/09/2011WO2011067160A1 Von willebrand factor specific binding agents and uses thereof
06/09/2011WO2010057036A3 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
06/09/2011US20110136911 Treatment of sepsis and inhibition of mif by d-t4
06/09/2011US20110136899 Combination of dronedarone with at least one diuretic, and therapeutic use thereof
06/09/2011US20110136881 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
06/09/2011US20110136828 Substituted n-oxide pyrazine derivatives
06/09/2011US20110136789 C-met protein kinase inhibitors
06/09/2011US20110136779 Methods for stroke reduction in atrial fibrillation patients
06/09/2011US20110136740 CYSTINE KNOT PEPTIDES BINDING TO ALPHA IIb BETA 3 INTEGRINS AND METHODS OF USE
06/09/2011US20110136739 Use of S1P Receptor Agonists in Heart Diseases
06/09/2011US20110136724 Analogues of glucose-dependent insulinotropic polypeptide
06/09/2011US20110135736 Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent
06/09/2011US20110135732 Multiple phase cross-linked compositions and uses thereof
06/09/2011US20110135650 Morpholinone compounds as factor ixa inhibitors
06/09/2011CA2782727A1 2-pyridone compounds
06/09/2011CA2782424A1 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
06/09/2011CA2781182A1 Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor
06/08/2011EP2330193A1 Improved antibody molecule
06/08/2011EP2329847A2 Use of an antibody or an immunotoxin that selectively binds to CD123 to impair hematologic cancer progenitor cells
06/08/2011EP2329024A1 An endogenous short hairpin rna and the use of the same
06/08/2011EP2328931A1 Anti-hepcidin-25 selective antibodies and uses thereof
06/08/2011EP2328926A1 Treatment of thrombocytopenia
06/08/2011EP2328619A2 Polymeric benzyl carbonate-derivatives
06/08/2011EP2328580A1 Dabigatran for percutaneous interventional cardiac catheterisation
06/08/2011CN1931336B Chinese medicine composition and its preparation process
06/08/2011CN1852736B Immunoglobulin chimeric monomer-dimer hybrids
06/08/2011CN1771978B Notoginseng triol-saponin composition and its preparation and use
06/08/2011CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
06/08/2011CN102088999A Von willebrand factor or factor VIII and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
06/08/2011CN102088978A Ameliorating or therapeutic agent for dyslipidemia
06/08/2011CN102088968A Blood substitute solution
06/08/2011CN102088954A An intrauterine delivery system for contraception
06/08/2011CN102086239A Preparation method of silkworm chrysalis chitosan derivatives with anticoagulation activities
06/08/2011CN102086232A Method for preparing polyferose
06/08/2011CN102085370A Oral spray for inflammatory diseases of oral cavity and preparation method thereof
06/08/2011CN102085332A Medicament for treating early ascites due to cirrhosis
06/08/2011CN102085318A Coix seed/ginseng buccal tablet and preparation method thereof
06/08/2011CN102085314A Chinese medicine for treating drug-resistant staphylococcus aureus septicemia
06/08/2011CN102085297A Traditional Chinese medicament for treating thrombus
06/08/2011CN102085296A Drug for treating cerebral thrombosis
06/08/2011CN102085253A Compound green vitriol capsule
06/08/2011CN102085250A Goldthread root dispersible tablets
06/08/2011CN102085233A Compound fortune euonymus capsule